Zonisamide cncentrations during pegnancy

Annals of Pharmacotherapy

Volumn 42, Issue 7-8, 2008, Pages 1139-1141

  Oles, Karen S ^a,b,c   Bell, William L ^b  

^a Department of Neurology ^*

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiepileptic medication; Pregnancy; Zonisamide

Indexed keywords

ZONISAMIDE; ANTICONVULSIVE AGENT; ISOXAZOLE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DRUG BLOOD LEVEL; FEMALE; FETUS OUTCOME; GRAND MAL EPILEPSY; HUMAN; MYOCLONUS SEIZURE; NEWBORN; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; BLOOD; MYOCLONUS EPILEPSY; PREGNANCY COMPLICATION; SEIZURE;

ADULT; ANTICONVULSANTS; FEMALE; HUMANS; ISOXAZOLES; MYOCLONIC EPILEPSY, JUVENILE; PREGNANCY; PREGNANCY COMPLICATIONS; SEIZURES;

EID: 48249142745     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L052     Document Type: Article

References (7)

1. Biton V. Clinical pharmacology and mechanism of action of zonisamide. Clin Neuropharmacol 2007;30:230-40.
2. Baulac M, Leppik IE. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Epilepsy Res 2007;75:75-83.
3. Product information. Zonegran (zonisamide). Research Triangle Park, NC: Eisai, Inc. http://zonegran.com/utilities/p.i.pdf (accessed 2008 Jan 2).
4. Kondo T, Kaneko S, Amano Y, Egawa I. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia 1996;37:1242-4.
5. Kawada K, Itoh S, Kusaka T, Isobe K, Ishii M. Pharmacokinetics of zonisamide in perinatal period. Brain Dev 2002;24:95-7.
6. Tomson T, Battino D. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 2007;46:209-19.
7. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter. Management issues for women with epilepsy (summary statement). Neurology 1998;51:944-8.